#WCLC25
LightNews LightNews
oncodaily.bsky.social
IASLC - What Attendees Can Expect from WCLC25
@iaslc.bsky.social
@stephenvliu.bsky.social
@narjustflorezmd.bsky.social
@drjnaidoo.bsky.social

oncodaily.com/blog/wclc25-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25 #IASLC
What Attendees Can Expect from WCLC25 - IASLC - OncoDaily
What Attendees Can Expect from WCLC25 - IASLC / cancer, IASLC, International Association for the Study of Lung Cancer, Isabelle Schmitt-Opitz, Jarushka
oncodaily.com
July 11, 2025 at 8:55 PM
oncodaily.bsky.social
WCLC25 Full Programme is Now Online - Herbert Loong
@herbloongmd.bsky.social

oncodaily.com/voices/herbe...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25
Herbert Loong: WCLC25 Full Programme is Now Online - OncoDaily
Herbert Loong: WCLC25 Full Programme is Now Online / ADCs, cancer, Herbert Loong, OncoDaily, Oncology, WCLC25
oncodaily.com
August 18, 2025 at 12:09 AM
oncodaily.bsky.social
Join Discussion on Treating Rare Lung Cancer Subtypes at WCLC25 - Stephen V Liu

@stephenvliu.bsky.social @solangepeters.bsky.social @mhennink.bsky.social

oncodaily.com/voices/steph...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #WCLC25
Stephen V Liu: Join Discussion on Treating Rare Lung Cancer Subtypes at WCLC25 - OncoDaily
Stephen V Liu: Join Discussion on Treating Rare Lung Cancer Subtypes at WCLC25 / cancer, Georgetown Lombardi Comprehensive Cancer Center, Merel Hennink,
oncodaily.com
August 24, 2025 at 12:30 AM
oncodaily.bsky.social
A Meaningful Week of Science at the WCLC25 - Narjust Florez

@narjustflorezmd.bsky.social

oncodaily.com/voices/narju...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25
Narjust Florez: A Meaningful Week of Science at the WCLC25 - OncoDaily
Narjust Florez: A Meaningful Week of Science at the WCLC25 / cancer, Lung cancer, Narjust Florez, OncoDaily, Oncology, WCLC25
oncodaily.com
September 18, 2025 at 12:42 PM
oncodaily.bsky.social
IASLC Quiz Winner at WCLC25 - Gerry Hanna

@gerryhanna.bsky.social @iaslc.bsky.social

oncodaily.com/voices/gerry...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25
Gerry Hanna: IASLC Quiz Winner at WCLC25 - OncoDaily
Gerry Hanna: IASLC Quiz Winner at WCLC25 / cancer, Fiona McDonald, Gerry Hanna, Houda Bahig, OncoDaily, Oncology, Sara Ramella, Stephen Liu, World
oncodaily.com
September 10, 2025 at 4:42 PM
oncodaily.bsky.social
WCLC25: Insights and Highlights from Dr. Stephen Liu

@stephenvliu.bsky.social @iaslc.bsky.social

oncodaily.com/insight/wclc...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25 #IASLC
WCLC25: Insights and Highlights from Dr. Stephen Liu - OncoDaily
WCLC25: Insights and Highlights from Dr. Stephen Liu / Caicun Zhou, cancer, cancer care, Corinne Faivre-Finn, IASLC, immunotherapy, John Varlotto, Mariano
oncodaily.com
September 9, 2025 at 12:27 PM
iaslc.bsky.social
🌍 It’s World Cancer Day! Let’s unite to advance lung cancer research & care.

🚨 WCLC 2025 registration & abstract submissions are OPEN!
📍 Barcelona | Sept 6–9, 2025

Be part of the future of lung cancer care.

Register now! 🔗 bit.ly/IASLCWCLC
#WCLC25 #WorldCancerDay
February 4, 2025 at 9:32 PM
drtomjohn.bsky.social
So much fun rehearsing some acoustic tunes with @drsanjaypopat.bsky.social - don’t forget to stick around after the #WCLC25 plenary tomorrow evening @iaslc.bsky.social
September 5, 2025 at 8:30 PM
drtomjohn.bsky.social
Looking forward to playing some tunes with my good friend and musician @drsanjaypopat.bsky.social tomorrow at #WCLC25. Make sure you stick around at the welcome reception Saturday evening!
September 5, 2025 at 10:07 AM
oncodaily.bsky.social
Best Slides of WCLC25 by Daniel Tan - Jarushka Naidoo

@drjnaidoo.bsky.social

oncodaily.com/voices/wclc2...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25
Jarushka Naidoo: Best Slides of WCLC25 by Daniel Tan - OncoDaily
Jarushka Naidoo: Best Slides of WCLC25 by Daniel Tan / cancer, Daniel Tan, FLAURA2, Jarushka Naidoo, NSCLC, OncoDaily, Oncology, WCLC25
oncodaily.com
September 16, 2025 at 1:47 PM
alkpositive.bsky.social
Congratulations to friends at Nuvalent on the exciting and pivotal #ARROS1 data released @iaslc.bsky.social #WCLC25. Proud to continue to collaborate on outcomes for our patient community globally. 💙
#LCSM
September 10, 2025 at 8:40 PM
vslim.bsky.social
#WCLC25 Our #JTO editors got many talents!

@drtomjohn.bsky.social @drsanjaypopat.bsky.social @jtoonline.bsky.social @iaslc.bsky.social
drtomjohn.bsky.social Prof Tom John @drtomjohn.bsky.social · Sep 6
Looking forward to playing with @drsanjaypopat.bsky.social - a lot of fun rehearsing covers and @mayhemtomi tracks. Check us out tonight @iaslc.bsky.social #wclc2025
September 6, 2025 at 9:22 AM
boehringerglobal.bsky.social
#NEWS: New data available in HER2 (ERBB2)-mutant non-small cell lung cancer (NSCLC) in patients with stable, asymptomatic, and active brain metastases – underscoring our commitment to patients’ greatest needs.  🧪

Learn more about our presentation at #WCLC25: go.boehringer.com/WdAhL
September 8, 2025 at 2:38 PM
oncodaily.bsky.social
WCLC 2025 Highlights: FLAURA2 trial

@iaslc.bsky.social

oncodaily.com/insight/wclc...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC #WCLC25 #FLAURA2 #IASLC
WCLC 2025 Highlights: FLAURA2 trial - OncoDaily
WCLC 2025 Highlights: FLAURA2 trial / Alessio Cortellini, Alfredo Addeo, Amit Kulkarni, Amol Akhade, Ana I. Velázquez Mañana, Antonio Calles, Bartomeu
oncodaily.com
September 7, 2025 at 4:44 PM
nejm.org
MARIPOSA phase 3 trial: In advanced non–small-cell lung cancer with EGFR mutations, amivantamab–lazertinib led to longer overall survival than osimertinib but was associated with an increased risk of adverse events of grade 3 or higher. nej.md/4p6j53k

#WCLC25 | @iaslc.bsky.social
Kaplan–Meier estimates of overall survival (assessed in an analysis of the time from randomization to death from any cause) among participants who received amivantamab–lazertinib and those who received osimertinib.
September 7, 2025 at 6:52 AM
brian-casey.bsky.social
Issue #736 of The Imaging Wire is live:

- Bayer Steps Back from Blackford
- WCLC25: Lung Screening Benefits Older Adults
- WCLC25: Early Results from Taiwan Lung Screening
- POCUS Reduces Hospital Length of Stay

Read more at theimagingwire.com/newsletter/b...

#radiology #WCLC25 #lungcancer
Bayer Steps Back from Blackford, WCLC 2025, and the Berlin Lawsuit - The Imaging Wire
Bayer steps back from Blackford, the Berlin Lawsuit, opening sessions from WCLC 2025, contaminated CT contrast sickens patients, and more.
theimagingwire.com
September 8, 2025 at 2:32 PM
mskdeptofmed.bsky.social
Tomorrow morning, #lungcancer expert Mark Kris will discuss clinicopathologic features of TP53/RB1-mutant squamous cell lung cancers at #WCLC25. #LCSM @iaslc.bsky.social @mskcancercenter.bsky.social

September 8 | 10:30 a.m.. CEST

➡️ bit.ly/41EZM7b
September 7, 2025 at 3:18 PM
mskdeptofmed.bsky.social
Don't miss an opportunity to learn from the Chief of the Thoracic Oncology Service at @mskcancercenter.bsky.social! At #WCLC25, Mark Awad will share lessons about work-life balance in high-stress medical careers. #LCSM @iaslc.bsky.social

September 7 | 1:45 p.m. CEST

➡️ bit.ly/3HTNpxr
September 7, 2025 at 10:45 AM
pearlf.bsky.social
The median overall survival of nearly 4 years appears to be the longest benefit ever reported in a global Phase III clinical trial #FLAURA2 in EGFR-mutated advanced lung cancer #WCLC25 #NSCLC #lcsm #medsky #biosky
pearlf.bsky.social Pearl Freier @pearlf.bsky.social · Sep 7
AstraZeneca's cancer drug Tagrisso in combination w/ chemotherapy showed median overall survival/OS of nearly 4 yrs in Phase 3 trial #FLAURA2 in EGFR-mutated advanced non-small cell lung cancer. Below is Penn Medicine medical oncologist & #lcsm expert's tweets from #WCLC25 #NSCLC #medsky #biosky
September 7, 2025 at 1:56 PM
mskdeptofmed.bsky.social
Happening tomorrow at #WCLC25: @mskcancercenter.bsky.social's @charlesrudin.bsky.social will highlight future directions in small cell #lungcancer research. Follow along for coverage of the latest advances. #LCSM #SCLC @iaslc.bsky.social

September 6 | 10:30 a.m. CEST

➡️ bit.ly/3HJJmnp
Charles Rudin looks at the camera in a white lab coat.
September 5, 2025 at 4:54 PM
alkpositiveuk.bsky.social
New research at #WCLC25 looked at a tool to support shared decision-making in ALK+ #LungCancer.

Choosing a first treatment isn’t only about the data - it’s about what matters most to each person: quality of life, side effects, work, family, or travel.

Decisions should be shared. #LCSM
September 14, 2025 at 4:29 PM
cancercommunicator.com
Final OS from FLAURA2 at #WCLC25:
osimertinib + chemo vs osimertinib alone in untreated advanced EGFR-mutated NSCLC.
👉 Median OS: 47.5 vs 37.6 mo (HR 0.77; p=0.02)
👉 3-yr OS: 63% vs 51% www.cancercommunicator.com/post/wclc25-... #LungCancer #NSCLC #Oncology #LCSM #CanSky #OncSky #MedSky
#WCLC25: Four-Year Median OS with Osimertinib/Chemotherapy Combination in Advanced EGFR-Mutation Positive NSCLC
The final overall survival (OS) analysis from the FLAURA2 trial was presented during the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC) Pres...
www.cancercommunicator.com
September 8, 2025 at 9:59 PM
jia-luo.bsky.social
What a fantastic IASLC WCLC25!

Congrats to star resident (onc-to-be!) Dr Huang &

We had a superb global multi-D discussion on ground glass/semisolid lung nodules - packed room in our last session of the day!

TY chairs Drs Naidoo Opitz Malapelle & Noemi - feeling inspired 🙏
@iaslc.bsky.social
September 10, 2025 at 3:40 AM
vslim.bsky.social
@iaslc.bsky.social @jtoonline.bsky.social #WCLC25 #peerreview
September 9, 2025 at 8:41 PM
lcrf.org
Learn what happens at September's World Conference for #LungCancer in Barcelona – no international travel needed! Our next Together Separately livestream will focus on news from this important meeting. Join us Thurs, Sept. 25 at 3:30 PM ET: LCRF.org/together

@stephenvliu.bsky.social #WCLC25
Together Separately: WCLC recap - Lung Cancer Research Foundation
This livestream is an opportunity to connect face-to-face with others who care about lung cancer. Our guest experts will discuss developments coming out of this year’s World Conference on Lung […]
LCRF.org
August 26, 2025 at 3:02 PM